Analysis and Review Liquid Biopsy Market

1. Liquid Biopsy Market January 2020 Report Id : REP-GB-1396 Published On : 2020-01-17 Category : Healthcare, Pharmaceuticals & Medical Devices www.futuremarketinsights.com I @futuremarketins I /company/future-market-insights © 2019 Future Market Insights, All Rights Reserved www.futuremarketinsights.com I @futuremarketins I /company/future-market-insights © 2019 Future Market Insights, All Rights Reserved

2. About Future Market Insights Future Market Insights (FMI) is a premier provider of syndicated research reports, custom research reports, and consulting services. We deliver a complete packaged solution, which combines current market intelligence, statistical anecdotes, technology inputs, valuable growth insights,aerial view of the competitiveframework,and future markettrends. We provide research services at a global as well as regional level; key regions include GCC, ASEAN, and BRIC. Our offerings cover a broad spectrum of industries including Chemicals, Materials, Energy, Technology,Healthcare, and Retail. We have a global presence with delivery centers across India specializing in providing global research reports and country research reports. FMI is headquartered out of London, U.K., with a state-of-the-art delivery center located in Pune, India. We combine our knowledge and learning from every corner of the world to distill it to one thing– the perfect solutionfor our client. Research Capabilities Sector Coverage ❑ ❑ ❑ ❑ ❑ ❑ ❑ ❑ ❑ ❑ ❑ ❑ Customized Research Syndicated Research Investment Research Social Media Research Automotive and Transportation Electronics, Semiconductor, and ICT Retail and Consumer Products Industrial Automation and Equipment Chemicals & Materials Food and Beverages Services and Utilities Energy, Mining, Oil, and Gas Customized Research Subscription Information Syndicated Research For detailed subscription information please contact Hari. T (Sr. Manager - Global Business Development) Investment Research T: +44 (0) 20 7692 8790 | D: +44 20 3287 4268 Email: hari.t@futuremarketinsights.com Social Media Research www.futuremarketinsights.com I @futuremarketins I /company/future-market-insights 2 © 2019 Future Market Insights, All Rights Reserved

3. Research Methodology (1/2) Systematic Research Approach 1 In-depth secondary research is used to ascertain overall market size, top industry players, top products, industry associations, etc. Research & Intelligence Data Collection Data Filter & Analysis Actionable Insights Business Solution Market profiling 2 FMI formulates a detailed discussion guide to conduct expert and industry interviews ❑ ❑ ❑ ❑ Identifying key opinion leaders Questionnaire design In-depth interviews Coverage across value chain Formulating discussion guide 3 A FMI develops a list of industry players (manufacturers), distributors, retailers and industry experts Primary Research ❑ ❑ ❑ ❑ ❑ ❑ Key industry experts Channel study Developments Market dynamics Products Conclusions Developing list of respondents B FMI conducts interviews with industry experts, industry players, distributors and retailers 4 SOLUTION Desk Research Data collection ❑ ❑ ❑ ❑ ❑ Market participants Key strengths Product portfolio Mapping as per value chain Key focus segments C Data is validated by triangulation method, wherein secondary, primary and FMI analysis contribute to the final data Company Analysis 5 Data validation Data is scrutinized using MS-Excel to obtain qualitative and quantitative insights about the industry 6 Data analysis Primary Research# Secondary Research # Paid Publications# ❑ ❑ ❑ ❑ ❑ ❑ ❑ ❑ ❑ ❑ Linkedin Zoominfo Salesforce Avention Company websites Company annual reports White papers Financial reports Factiva GBI Genios Meltwater FMI delivers industry insights and information in the required format (PDF) 7 Insights ❑ ❑ # includes sources of databases www.futuremarketinsights.com I @futuremarketins I /company/future-market-insights 3 © 2019 Future Market Insights, All Rights Reserved

4. Liquid Biopsy Market Analysis This report by Future Market Insights (FMI) examines the ‘Liquid Biopsy Market’ for the period 2016– 2026. The primary objective of the report is to offer updates and information related to market opportunities in the global liquid biopsy market. Report Description The global liquid biopsy market report begins by defining liquid biopsy and various types of markers used in liquid biopsy. It is followed by an overview of market dynamics of the global liquid biopsy market, which includes FMI’s analysis of key trends, drivers, restraints and opportunities, and reimbursement scenario that is influencing the growth of the liquid biopsy market. It also includes an insight into case- studies and product pipeline. Impact analysis of key growth drivers and restraints based on a weighted average model have been included in the global liquid biopsy market report after detailed analysis of individual regions to better equip readers with meaningful insights on ongoing developments in the oncology market. The primary factors fuelling demand for liquid biopsy diagnostic tests are growing incidences of lung, gastrointestinal and breast cancer. Other factors driving demand for liquid biopsy tests are increasing inclination of oncologists and physician to opt for non-invasive diagnostic procedures, reluctance of the www.futuremarketinsights.com I @futuremarketins I /company/future-market-insights 4 © 2019 Future Market Insights, All Rights Reserved

5. Liquid Biopsy Market Analysis patients to go painful biopsies and increase in the demand of personalized medicine. Whereas increasing number of test launches and entry of regional players also drives the market for liquid biopsy tests. However, a primary factor hampering growth of the liquid biopsy market is its penetration owing lower awareness of blood tests to detect cancer. Based on market type, the market has been segmented into circulating tumour cells (CTCs), Circulating tumour Nucleic Acids (ctNA) and exosomes. A detailed analysis has been provided for these segment in terms of market size, Y-o-Y growth rate, absolute $ opportunity and BPS analysis. Based on sample type, the market has been segmented into blood, urine and others (plasma, saliva, CSF). Our analysis predicts that biopsies through blood samples would increase at a very fast pace, increasing the number of blood diagnostic test to detect cancer is expected to contribute significantly to increasing demand for liquid biopsies the forecast period. Any Queries, ask us @ https://www.futuremarketinsights.com/ask-question/rep-gb-1396 Based on the disease indication the liquid biopsy market has been segmented into lung cancer, gastrointestinal cancer, prostate cancer, breast cancer, colorectal cancer, leukemia and others. www.futuremarketinsights.com I @futuremarketins I /company/future-market-insights 5 © 2019 Future Market Insights, All Rights Reserved

6. Liquid Biopsy Market Analysis Lung cancer is expected to expand at a higher CAGR, due to increasing prevalence of lung cancer over the forecast period. Further, based on end-user segmentation, the market is segmented into hospitals, cancer institutes, academic institutes and diagnostic centres. Increasing commercialization of liquid biopsy test is expected to increase the revenue generation of liquid biopsies from hospitals and diagnostic centres surgery. This trend is expected to be particularly prominent in countries where access to healthcare services is increasing especially in APEJ The next section of the report highlights liquid biopsy market by region and provides market outlook for 2016–2026. The report also discusses key regional trends contributing to the revenue growth of the liquid biopsy tests worldwide, as well as analyses the impact of drivers and restraints in each region. Key regions assessed in this report include North America, Latin America, Western Europe, Eastern Europe, Asia Pacific Excluding Japan (APEJ), Japan and Middle East & Africa (MEA). The above sections—by marker type, sample type, disease indication, end users and region—evaluate the present scenario and growth prospects of the liquid biopsy tests market for 2016–2026. We have considered 2015 as the base year and provided data for the forecast period, i.e., 2016–2026. www.futuremarketinsights.com I @futuremarketins I /company/future-market-insights 6 © 2019 Future Market Insights, All Rights Reserved

7. Liquid Biopsy Market Analysis To ascertain liquid biopsy tests market size, we have also considered revenue generated by companies in liquid biopsy market space. The forecast presented here assesses the total revenue by value across the liquid biopsy market. In order to offer an accurate forecast, we started by sizing up the current market, which forms the basis of how the liquid biopsy market is expected to develop in the future. Given the characteristics of the market, we triangulated the outcome of three different types of analysis based on supply side, downstream industry demand, and the economic envelope. In addition, it is imperative to note that in an ever-fluctuating global economy, we not only conduct forecasts in terms of CAGR, but also analyse it based on key parameters such as year-on-year (Y-o-Y) growth rates to understand the predictability of the market, and to identify the right opportunities across the global liquid biopsy market. The liquid biopsy market segments in terms of marker type, sample type, disease indication, end user, and regions. These segments are analysed in terms of Basis Point Share (BPS) to understand individual segment’s relative contributions to market growth. This detailed level of information is important for identifying various key trends in the liquid biopsy market. www.futuremarketinsights.com I @futuremarketins I /company/future-market-insights 7 © 2019 Future Market Insights, All Rights Reserved

8. Liquid Biopsy Market Analysis Another key feature of this report is the analysis of key segments in terms of absolute dollar opportunity. This is overlooked while forecasting the market. However, absolute dollar opportunity is critical for assessing the level of opportunity that a provider can look to achieve, as well as to identify potential resources from a sales and delivery perspective, in the global liquid biopsy market. To understand key growth segments in terms of growth and adoption for liquid biopsy tests globally, Future Market Insights developed the liquid biopsy market ‘Attractiveness Index’. The resulting index is expected to help providers identify real market opportunities in the overall oncology market. In the final section of the report on the global liquid biopsy market, ‘Competitive Landscape’ is included to provide report audiences with a dashboard view, based on categories of test developers in the liquid biopsy market space and key differentiators. Key categories of providers covered in the report are companies developing liquid biopsy tests. This section is primarily designed to provide clients with an objective and detailed comparative assessment of key providers specific to a market segment in the liquid biopsy value chain and the potential players for the same. Report audiences can gain segment- specific company insights to identify and evaluate key competitors based on in-depth assessment of capabilities and successes in liquid biopsy marketplace. www.futuremarketinsights.com I @futuremarketins I /company/future-market-insights 8 © 2019 Future Market Insights, All Rights Reserved

9. Liquid Biopsy Market Analysis Detailed profiles of the liquid biopsy tests developing companies are also included in the scope of the report to evaluate their long- and short-term strategies, key offerings, SWOT analysis, and recent developments in the global liquid biopsy market. Key competitors covered in terms of liquid biopsy test developing companies BIOCEPT, INC., Qiagen N.V., Trovagene, Inc., Janssen Global Services, LLC, MDxHealth SA, Natera, Inc., F. Hoffmann-La Roche Ltd., Silicon Biosystems, Pathway Genomics Corporation, Sysmex Corporation. Key Segments Covered By Marker Type • CTCs (Circulating tumour Cells) o ctNA (Circulating tumour Nucleic Acids) o Exosomes o By Sample Type • www.futuremarketinsights.com I @futuremarketins I /company/future-market-insights 9 © 2019 Future Market Insights, All Rights Reserved

10. Liquid Biopsy Market Analysis Blood o Urine o Others (Plasma, Saliva, CSF) o By Disease Indication • Lung Cancer o Gastrointestinal Cancer o Prostate Cancer o Breast Cancer o Colorectal Cancer o Leukemia o Others o www.futuremarketinsights.com I @futuremarketins I /company/future-market-insights 10 © 2019 Future Market Insights, All Rights Reserved

11. Liquid Biopsy Market Analysis By End-User • Hospitals o Cancer Institutes o Academic Institutes o Diagnostic Centers o Visit For Report TOC @ https://www.futuremarketinsights.com/reports/liquid-biopsy-market/table-of- content Click here to Order a free sample www.futuremarketinsights.com I @futuremarketins I /company/future-market-insights 11 © 2019 Future Market Insights, All Rights Reserved

12. To know more about us, please visit our website: www.futuremarketinsights.com For sales queries or new topics email us on: sales@futuremarketinsights.com For media queries, contact the press office at press@futuremarketinsights.com For other queries contact: Hari. T (Sr. Manager - Global Business Development) Future Market Insights: 3rd Floor, 207 Regent Street, London W1B 3HH T: +44 20 7692 8790 | D: +44 20 3287 4268 Email: hari.t@futuremarketinsights.com Future Market Insights Global & Consulting Private Limited (FMI) Thank You www.futuremarketinsights.com I @futuremarketins I /company/future-market-insights 12 © 2019 Future Market Insights, All Rights Reserved